Chemical Structure : Atrasentan
CAS No.: 173937-91-2
Catalog No.: PC-21324Not For Human Use, Lab Use Only.
Atrasentan (ABT-627, A-147627) is a potent, selective and orally active nonpeptide endothelin A-receptor (ETA) with IC50 of 0.055 nM.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $98 | In stock | |
10 mg | $148 | In stock | |
25 mg | $258 | In stock | |
50 mg | $428 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Atrasentan (ABT-627, A-147627) is a potent, selective and orally active nonpeptide endothelin A receptor (ETA) with IC50 of 0.055 nM.
Atrasentan (ABT-627, A-147627) significantly inhibits LNCaP and C4-2b prostate cancer cell growth.
Atrasentan (ABT-627, A-147627) inhibits ET-1 radioligand binding with IC50 of 0.36 nM, 1000-fold selectivity for the ET(A) vs the ET(B) receptor.
Atrasentan (ABT-627, A-147627) also is a potent inhibitor (IC50=0.16 nM) of phosphoinositol hydrolysis stimulated by ET-1, and it antagonizes the ET-1-induced contraction of the rabbit aorta with a pA(2)=9.20.
M.Wt | 510.63 | |
Formula | C29H38N2O6 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(2r,3r,4s)-4-(benzo[d][1,3]dioxol-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylicacid |
1. Winn M, et al. J Med Chem. 1996 Mar 1;39(5):1039-48.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright